title: [Complete regression of Barrett's esophagus after drug therapy].
abstract: Barrett's esophagus is defined as a disorder in which the normal stratified squamous mucosa of the esophagus is replaced by columnar epithelium. Patients with Barrett's esophagus are at risk to develop an adenocarcinoma of the esophagus. Pathologic gastroesophageal reflux is correlated to the disease and therapeutical options must aim to stop this noxa in order to prevent columnar metaplasia, and subsequent dysplasia and/or neoplasia. The Authors report the case of a patient in whom the complete regression of the metaplasia was observed after medical therapy.
authors.affiliation: Divisione di Chirurgia Generale, Ospedale S. Carlo di Genova.
authors.forename: M
authors.initials: M
authors.lastname: Pasqualini
authors.forename: P G
authors.initials: PG
authors.lastname: Farina
authors.forename: M
authors.initials: M
authors.lastname: Livorti
authors.forename: F
authors.initials: F
authors.lastname: Petrogalli
authors.forename: R
authors.initials: R
authors.lastname: Romanelli
authors.forename: C
authors.initials: C
authors.lastname: Schenardi
mesh_terms: D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D001471:Barrett Esophagus / Q000188:drug therapy* / Q000473:pathology; D001706:Biopsy; D004359:Drug Therapy, Combination; D004947:Esophagus / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011899:Ranitidine / Q000008:administration & dosage; D013392:Sucralfate / Q000008:administration & dosage
chemical_list: D000897:Anti-Ulcer Agents; D013392:Sucralfate; D011899:Ranitidine